| 1 |
33297669 |
10.3324/haematol.2020.267294 |
2022 |
Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas. |
KRAS |
| 2 |
34472720 |
10.1002/cnr2.1545 |
2022 |
Genetic features of precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement. |
KRAS |
| 3 |
35240014 |
10.4143/crt.2022.017 |
2022 |
Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas. |
KRAS |
| 4 |
35363510 |
10.1200/JCO.21.02840 |
2022 |
Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial. |
KRAS |
| 5 |
35484682 |
10.3324/haematol.2021.280557 |
2022 |
Molecular characterisation and clinical outcome of B-cell precursor acute lymphoblastic leukaemia with IG-MYC rearrangement. |
KRAS |
| 6 |
32929178 |
10.1038/s41379-020-00673-x |
2021 |
The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy. |
KRAS |
| 7 |
33393503 |
10.1172/JCI133090 |
2021 |
BCL6 confers KRAS-mutant non-small-cell lung cancer resistance to BET inhibitors. |
KRAS |
| 8 |
33506327 |
10.1007/s00428-021-03032-6 |
2021 |
Undifferentiated large cell/rhabdoid carcinoma presenting in the intestines of patients with concurrent or recent non-small cell lung cancer (NSCLC): clinicopathologic and molecular analysis of 14 cases indicates an unusual pattern of dedifferentiated metastases. |
KRAS |
| 9 |
34412631 |
10.1186/s12935-021-02143-z |
2021 |
Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-κB-related signaling. |
KRAS |
| 10 |
34447369 |
10.3389/fimmu.2021.671755 |
2021 |
Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management. |
KRAS |
| 11 |
34570179 |
10.1182/bloodadvances.2021004668 |
2021 |
Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies. |
KRAS |
| 12 |
34584457 |
10.2147/CMAR.S317319 |
2021 |
Myelin and Lymphocyte Protein (MAL): A Novel Biomarker for Uterine Corpus Endometrial Carcinoma. |
KRAS |
| 13 |
31439678 |
10.3324/haematol.2019.230375 |
2020 |
Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups. |
KRAS |
| 14 |
31807922 |
10.1007/s00428-019-02691-w |
2020 |
Subsequent development of histiocytic sarcoma and follicular lymphoma: cytogenetics and next-generation sequencing analyses provide evidence for transdifferentiation of early common lymphoid precursor-a case report and review of literature. |
KRAS |
| 15 |
31443309 |
10.3390/medicina55080490 |
2019 |
Malignant Pleural Effusion and Its Current Management: A Review. |
KRAS |
| 16 |
29439113 |
10.1136/gutjnl-2016-312608 |
2018 |
Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment. |
KRAS |
| 17 |
29486633 |
10.1177/1533034618754475 |
2018 |
Loss of ARID1A Expression Correlates With Tumor Differentiation and Tumor Progression Stage in Pancreatic Ductal Adenocarcinoma. |
KRAS |
| 18 |
29708356 |
10.14735/amko2018130 |
2018 |
MAPK/ERK signal pathway alterations in patients with Langerhans Cell Histiocytosis. |
KRAS |
| 19 |
29735551 |
10.1158/0008-5472.CAN-17-4004 |
2018 |
Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses. |
KRAS |
| 20 |
28122867 |
10.1158/2159-8290.CD-16-0330 |
2017 |
The Genetic Basis of Hepatosplenic T-cell Lymphoma. |
KRAS |
| 21 |
28246485 |
10.3748/wjg.v23.i6.1106 |
2017 |
Coexisting tubular adenoma with a neuroendocrine carcinoma of colon allowing early surgical intervention and implicating a shared stem cell origin. |
KRAS |
| 22 |
28280620 |
10.21037/jgo.2017.01.14 |
2017 |
Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in situ hybridization, and mutational analysis. |
KRAS |
| 23 |
25663566 |
10.1007/s12016-015-8466-y |
2016 |
Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS). |
KRAS |
| 24 |
27034005 |
10.18632/oncotarget.8427 |
2016 |
Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles. |
KRAS |
| 25 |
27600764 |
10.1038/ncomms12602 |
2016 |
Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations. |
KRAS |
| 26 |
27672108 |
10.1093/annonc/mdw282 |
2016 |
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas. |
KRAS |
| 27 |
25842168 |
10.1016/j.ctrv.2015.03.009 |
2015 |
Beyond EGFR and ALK inhibition: unravelling and exploiting novel genetic alterations in advanced non small-cell lung cancer. |
KRAS |
| 28 |
26358176 |
10.1038/cgt.2015.39 |
2015 |
A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance. |
KRAS |
| 29 |
19551857 |
10.1002/ijc.24681 |
2009 |
The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms. |
KRAS |
Datasets
Models
